Artiva Biotherapeutics, Inc. ARTV Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s change in accrued liabilities?
- Artiva Biotherapeutics, Inc. (ARTV) reported change in accrued liabilities of -$4M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s change in accrued liabilities changed year-over-year?
- Artiva Biotherapeutics, Inc.'s change in accrued liabilities decreased by 330.0% year-over-year, from -$931K to -$4M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.